首页> 外文期刊>BioMed research international >Evaluation of Influence of Various Polymers on Dissolution and Phase Behavior of Carhamazepine-Succinic Acid Cocrystal in Matrix Tablets
【24h】

Evaluation of Influence of Various Polymers on Dissolution and Phase Behavior of Carhamazepine-Succinic Acid Cocrystal in Matrix Tablets

机译:各种聚合物对基质片中甲酰胺 - 琥珀酸COCRYSTAL溶解和相行为的影响评价

获取原文
获取原文并翻译 | 示例
           

摘要

Ihe aim of current study was to explore the influence of three commonly used polymers, that is, cellulosics and noncellulosics, for example, Methocel K4M, Kollidon VA/64, and Soluplus, on the phase disproportionation and drug release profile of carbamazepine-succinic acid (CBZ-SUC) cocrystal at varying drug to polymer ratios (1:1 to 1:0.25) in matrix tablets. The polymorphic phase disproportionation during in-depth dissolution studies of CBZ-SUC cocrystals and its crystalline properties were scrutinized by X-ray powder diffractrometry and Raman spectroscopy. The percent drug release from HPMC formulations (CSH) showed inverse relation with the concentration of polymer; that is, drug release increased with decrease in polymer concentration. On contrary, direct relation was observed between percent drug release and polymer concentrations of Kollidon VA 64/Soluplus (CSK, CSS). At similar polymer concentration, drug release from pure carbamazepine was slightly lower with HPMC formulations than that of cocrystal; however, opposite trend in release rate was observed with Kollidon VA/64 and Soluplus. The significant increase in dissolution rate of cocrystal occurred with Kollidon VA/64 and Soluplus at higher polymer concentration. Moreover, no phase change took place in Methocel and Kollidon formulations. No tablet residue was left for Soluplus formulation so the impact of polymer on cocrystal integrity cannot be predicted.
机译:目前研究的目的是探讨三种常用聚合物的影响,即纤维素和非纤维素,例如,Methocel K4M,Kollidon Va / 64和Soluplus,对Carbamazepine-琥珀酸的相歧化和药物释放曲线(CBZ-SUC)在基质片中的不同药物中的聚合物比(1:1至1:0.25)的聚合物。通过X射线粉末差异和拉曼光谱仔细地仔细地仔细地筛选了CBZ-SUC COCrystals的深入溶解研究期间的多态性相歧化及其结晶性能。 HPMC制剂(CSH)的药物释放百分比显示与聚合物浓度的反向关系;也就是说,药物释放随着聚合物浓度的降低而增加。相反,观察到kollidon va 64 / soluplus(Csk,Css)的百分比药物释放和聚合物浓度之间的直接关系。在类似的聚合物浓度下,纯碳碱的药物释放略低于HPMC制剂,而不是COCrystal;然而,用kollidon va / 64和soluplus观察到释放速率的相反趋势。通过kollidon va / 64和较高的聚合物浓度的kollidon va / 64和soluplus发生显着增加。此外,在Methocel和Kollidon制剂中未发生相变。对于Soluplus制剂没有片剂残留物,因此不能预测聚合物对COCrystal完整性的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号